To include your compound in the COVID-19 Resource Center, submit it here.

Samsung BioLogics sets sights on Korean IPO

Contract manufacturer Samsung BioLogics (Seoul, South Korea) is planning to

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE